Linked Life Data

12099908

Source:http://linkedlifedata.com/resource/pubmed/id/12099908

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-7-8
pubmed:abstractText
Narp is an immediate early gene product that acts extracellularly to cluster AMPA receptors at excitatory synapses. The present study tested the hypothesis that drugs of abuse alter Narp expression and thereby influence AMPA receptor transmission in addiction-related circuits. Immunohistochemical studies demonstrated the existence of Narp-positive cells in hippocampus, prefrontal cortex (PFC) and nucleus accumbens (NAc), with lower levels of staining in the ventral tegmental area (VTA). To study the effects of psychomotor stimulants, Narp levels were quantified by Western blotting and normalized to actin. There were no differences in Narp levels in any brain region between rats treated with repeated saline injections, a single amphetamine injection (5 mg/kg), repeated amphetamine injections (5 mg/kg x 5 days), or repeated cocaine injections (20 mg/kg twice daily x 7 days). We also examined the possible role of Narp in individual differences in responding to a novel environment, a predictor of behavioural responses to psychomotor stimulant drugs including the propensity to acquire drug self-administration. Narp levels in the PFC, but not other regions, were significantly correlated with locomotor activity in a novel environment. These findings suggest that differential Narp expression in the PFC may be involved in determining individual vulnerability to drugs of abuse, perhaps by influencing the activity of its excitatory projections.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0953-816X
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2027-36
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12099908-Amphetamine, pubmed-meshheading:12099908-Animals, pubmed-meshheading:12099908-Brain, pubmed-meshheading:12099908-C-Reactive Protein, pubmed-meshheading:12099908-Cocaine, pubmed-meshheading:12099908-Drug Administration Schedule, pubmed-meshheading:12099908-Drug Tolerance, pubmed-meshheading:12099908-Exploratory Behavior, pubmed-meshheading:12099908-Genetic Variation, pubmed-meshheading:12099908-Male, pubmed-meshheading:12099908-Motor Activity, pubmed-meshheading:12099908-Nerve Tissue Proteins, pubmed-meshheading:12099908-Neural Pathways, pubmed-meshheading:12099908-Nucleus Accumbens, pubmed-meshheading:12099908-Prefrontal Cortex, pubmed-meshheading:12099908-Rats, pubmed-meshheading:12099908-Rats, Sprague-Dawley, pubmed-meshheading:12099908-Substance-Related Disorders, pubmed-meshheading:12099908-Up-Regulation, pubmed-meshheading:12099908-Ventral Tegmental Area
pubmed:year
2002
pubmed:articleTitle
Amphetamine and cocaine do not increase Narp expression in rat ventral tegmental area, nucleus accumbens or prefrontal cortex, but Narp may contribute to individual differences in responding to a novel environment.
pubmed:affiliation
Department of Neuroscience, The Chicago Medical School, North Chicago, IL 60064, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't